Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.5773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Nazleen F Khan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass…. Hauptthemen laut MEDLINE: Osteoarthritis, Fractures, Bone, Prescription Drugs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIA NIH HHS, AHRQ HHS.
Abstract (Originalsprache)
Background
Osteoarthritis (OA) patients taking prescription opioids for pain are at increased risk of fall or fracture, and the concomitant use of interacting drugs may further increase the risk of these events.
Aims
To identify prescription opioid‐related medication combinations associated with fall or fracture. Materials & Methods We conducted a case‐crossover‐based screening of two administrative claims databases spanning 2003 through 2021. OA patients were aged 40 years or older with at least 365 days of continuous enrollment and 90 days of continuous prescription opioid use before their first eligible fall or fracture event. The primary analysis quantified the odds ratio (OR) between fall and non‐opioid medications dispensed in the 90 days before the fall date after adjustment for prescription opioid dosage and confounding using a case‐time‐control design. A secondary analogous analysis evaluated medications associated with fracture. The false discovery rate (FDR) was used to account for multiple testing.
Results
We identified 41 693 OA patients who experienced a fall and 24 891 OA patients who experienced a fracture after at least 90 days of continuous opioid therapy. Top non‐opioid medications by ascending p‐value with OR > 1 for fall were meloxicam (OR 1.22, FDR = 0.08), metoprolol (OR 1.06, FDR >0.99), and celecoxib (OR 1.13, FDR > 0.99). Top non‐opioid medications for fracture were losartan (OR 1.20, FDR = 0.80), alprazolam (OR 1.14, FDR > 0.99), and duloxetine (OR 1.12, FDR = 0.97).
Conclusion
Clinicians may seek to monitor patients who are co‐prescribed drugs that act on the central nervous system, especially in individuals with OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Orthopedics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
ORCID-Profile: Nazleen F Khan, Katsiaryna Bykov, Robert J Glynn, Seoyoung C Kim
Förderung
- NIAMS NIH HHS
- NIA NIH HHS
- AHRQ HHS
- National Institute on Aging
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Khan, N. F., Bykov, K., Katz, J. N., Glynn, R. J., Vine, S. M., & Kim, S. C. (2024). Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5773
Vancouver
Khan NF, Bykov K, Katz JN, Glynn RJ, Vine SM, Kim SC. Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5773
BibTeX
@article{Khan2024,
author = {Khan, Nazleen F and Bykov, Katsiaryna and Katz, Jeffrey N and Glynn, Robert J and Vine, Seanna M and Kim, Seoyoung C},
title = {Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patients},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.5773}
}
EUVIMED